http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Futagami, Masayuki,Yokoyama, Yoshihito,Sato, Tetsumi,Hirota, Kazuyoshi,Shimada, Muneaki,Miyagi, Etsuko,Suzuki, Nao,Fujimura, Masaki Asian Pacific Journal of Cancer Prevention 2016 Asian Pacific journal of cancer prevention Vol.17 No.10
Purpose: To evaluate palliative care for patients with gynecologic cancer in Japan. Materials and Method: A questionnaire asking facility characteristics, systems to coordinate palliative care, current status of end-of-life care, provision of symptom relief, palliative radiation therapy and chemotherapy, and cases of death from gynecological cancer, was mailed to facilities treating gynecologic cancer. Results: A total of 115 facilities (29.3% of the total) responded to the questionnaire. Of these, 33.0 (29.0%) had a palliative care ward. End-of-life care was managed by obstetricians and gynecologists in 72.0% of the facilities. The site where end-of-life care was provided was most often a ward in the department where the respondent worked. The waiting period for transfer to a hospice was 2 weeks or more in 52% of facilities. Before the start of primary treatment, pain control was managed by obstetrians and gynecologists in 98.0% of facilities. Palliative radiation therapy or chemotherapy was administered at 93.9% and 92.0% of facilities, respectively. Of the 115 facilities, 34.0 (29.6%) reported cases of death from gynecological cancer. There were 1,134 cases of death. The median time between the last cycle of chemotherapy and death was 85 days for all gynecological cancers. The proportion of patients receiving chemotherapy in the last 30 and 14 days of life were 17.4% and 7.1%, respectively. Conclusions: This large-scale survey showed characteristics of palliative care given to patients with gynecologic cancer in Japan. Assessment of death cases showed that the median time between the last cycle of chemotherapy and death was relatively short.
문헌 초역 : 폐결핵 환자의 기관내 채담에 의한 결핵균의 검색, "트레핀"에 의한 경피폐생검
( Kohei Hara ),( Toshiro Oda ),( Masao Nakatomi ),( Nobuhiro Horiuchi ),( Tuneo Tsutsumi ),( Masaki Hirota ),( Nobuoki Mori ),( Masaru Nasu ),( Atsushi Seito ),( Hisashi Ishikawa ),( E. Garner King ) 대한결핵 및 호흡기학회 1977 Tuberculosis and Respiratory Diseases Vol.24 No.1
Total Synthesis of Pactalactam, an Imidazolidinone-Type Pactamycin Analogue
Kim, Taejung,Matsushita, Shohei,Matsudaira, So,Doi, Tsuyoshi,Hirota, Shinji,Park, Young-Tae,Igarashi, Masayuki,Hatano, Masaki,Ikeda, Noriko,Ham, Jungyeob,Nakata, Masaya,Saikawa, Yoko THE AMERICAN CHEMICAL SOCIETY 2019 ORGANIC LETTERS Vol.21 No.10
<P>The first total synthesis of pactalactam was accomplished using substrate-controlled stereoselective aziridination and regioselective aziridine ring-opening to construct three continuous amino groups on an octasubstituted cyclopentane core. The cyclopentane framework was obtained by ring-closing metathesis and aldol coupling using a <SMALL>L</SMALL>-threonine-derived oxazoline compound. Cyclic urea formation, <I>m</I>-acetylphenyl group introduction by Chan-Lam coupling, and primary alcohol-selective acylation yielded the reported pactalactam structure. The presence of pactalactam in the fermentation broth of pactamycin-producing bacteria was also confirmed.</P> [FIG OMISSION]</BR>